EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
EZZ Life Science Holdings Ltd. reported a stellar financial year, with a remarkable 78.9% revenue growth, fueled by strategic product innovation and expansion into international markets. The company’s EBITDA more than doubled, reaching $10.4 million, while maintaining strong gross margins above 75%. These achievements, supported by a robust cash position and no significant debt, poise EZZ for continued growth and shareholder value.
For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Netflix (NASDAQ:NFLX) Is on the Hunt for Anime Leakers
- String of Ford (NYSE:F) Model News Prompts Upswing
- Intel’s (INTC) CHIPS Act Funding May Be Cut, According to New York Times
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
